Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Vazalore (PL-ASA) 81 mg vs EC-ASA in Healthy Volunteers
NCT04811625Phase 4Completed
- Sponsor
- PLx Pharma Inc.
- Start
- Apr 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omecamtiv mecarbil in cardiovascular disease (CVD), sponsored by PLx Pharma Inc.. Started Apr 2021; status: completed.
02
Drugs
omecamtiv mecarbil
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT04811625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04811625.